论文部分内容阅读
目的观察实施临床路径对ST段抬高型急性心肌梗死(STEMI)急诊冠脉介入PCI患者的临床效果。方法以郏县人民医院心内科收治的诊断为STEMI并行急诊PCI患者为研究对象,收集干预前2008年2月至2013年12月STEMI急诊PCI患者50例为对照组,按常规方法治疗,收集2013年1月至2014年2月诊断为STEMI急诊PCI患者50例为治疗组,按临床路径控制模式治疗,比较两组患者就诊至球囊扩张(D-B)时间、心血管事件发生、住院时间、健康教育知晓情况、满意度等。结果治疗组在D-B时间、住院时间及心血管事件发生率均显著低于对照组,在健康教育内容方面掌握及满意度均显著高于对照组,差异有统计学意义(P<0.05)。结论对STEMI急诊PCI患者实施临床路径可缩短D-B时间,减少心血管事件的发生率,缩短了住院时间,确保了医疗安全,规范了临床医务人员的医疗行为。
Objective To observe the clinical effect of clinical pathways on STEMI emergency PCI patients. Methods 50 cases of STEMI emergency PCI patients from January 2008 to December 2013 were enrolled in the study. The patients with STEMI concurrent emergency PCI admitted to the Department of Cardiology, Yixian People’s Hospital were enrolled as the control group. The patients were followed up for 2013 From January to February 2014, 50 patients with STEMI emergency PCI were enrolled as the treatment group and treated according to the clinical pathway control mode. The patients in both groups were followed up for balloon dilation (DB), cardiovascular events, hospital stay, health Education awareness, satisfaction and so on. Results The D-B time, hospitalization time and the incidence of cardiovascular events in the treatment group were significantly lower than those in the control group. The levels of satisfaction and satisfaction in the content of health education were significantly higher than those in the control group (P <0.05). Conclusion The implementation of clinical pathology in STEMI emergency PCI patients can shorten the D-B time, reduce the incidence of cardiovascular events, shorten the hospital stay, ensure medical safety and standardize the medical behaviors of clinicians.